Co-development of drugs and companion diagnostics might need timely and coordinated
approval decisions from different bodies to meet the requirements of joint clinical trial
schemes and eventually the approval of both the drug and its associated test. In addition,
the path to get a stratified indication approved is not always clear. In this respect, the
status of retrospective analysis deserves clarification. Besides, the concept of qualification
is evolutionary and clear guidelines are missing.
(BQ) Part 1 book "Molecular histopathology and tissue biomarkers in drug and diagnostic development" presentation of content: Final recommendations, three companion diagnostic development paths, implementing a multi analyte immunohistochemistry panel into a drug development program, cutpoint methods in digital pathology and companion diagnostics,...
Widely recognised as the best starting point for pharmacology study, the internationally best-selling Medical Pharmacology at a Glance is an ideal companion for all students of the health sciences.
Key principles are supported by coloured schematic diagrams - invaluable as both an introduction to medical pharmacology, and revision in the run-up to pharmacology exams.